![](/img/cover-not-exists.png)
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
Iannantuoni, Francesca, M. de Marañon, Aranzazu, Diaz-Morales, Noelia, Falcon, Rosa, Bañuls, Celia, Abad-Jimenez, Zaida, Victor, Victor M., Hernandez-Mijares, Antonio, Rovira-Llopis, SusanaVolume:
8
Journal:
Journal of Clinical Medicine
DOI:
10.3390/jcm8111814
Date:
November, 2019
File:
PDF, 1.05 MB
2019